Drug Profile
Coronavirus vaccine - Zydus Cadila
Latest Information Update: 29 Jul 2020
Price :
$50
*
At a glance
- Originator Zydus Cadila
- Class Attenuated vaccines; COVID-19 vaccines; Synthetic vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Preclinical COVID 2019 infections